Guilherme Thomé de Carvalho
Guilherme Thomé de Carvalho has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Flavio Mac Cord Medina
Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
3 shared publications - Mário Martins dos Santos Motta
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
2 shared publications - Annamaria Ciminelli Barbosa
Department of Ophthalmology, Gaffree and Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro 20270-004, RJ, Brazil
1 shared publication - Bruno Frujuelli de Melo
Department of Ophthalmology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication Bruno Vasconcelos Coimbra
1 shared publication- Bruno Vasconcelos Coimbra
Hospital Universitário Gaffrée e Guinle Universidade Federal do Estado do Rio de Janeiro Rio de Janeiro RJ Brazil
1 shared publication
Latest Publications
- 23 December 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
A Refined Approach for Closing Refractory Macular Holes Using Subretinal BSS Injection
Purpose: To present a refined technique utilizing subretinal injection of Balanced Salt Solution (BSS) for the closure of refractory macular holes. Methods: This case report details a 70-year-old female patient with a refractory macular hole in the left eye, who underwent pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, gas tamponade, and subretinal injection of BSS. Results: One month postoperatively, optical coherence tomography (OCT) confirmed successful closure of the macular hole, with best-corrected visual acuity (BCVA) improving to 20/100 in the affected eye. At six-month follow-up, the macular hole remained closed, and OCT revealed partial restoration of the ellipsoid zone and external limiting membrane. BCVA was maintained at 20/100. Conclusion: Subretinal BSS injection appears to be an effective technique for closing refractory macular holes, offering a promising option for complex cases.
- 23 December 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
A Refined Approach for Closing Refractory Macular Holes Using Subretinal BSS Injection
Purpose: To present a refined technique utilizing subretinal injection of Balanced Salt Solution (BSS) for the closure of refractory macular holes. Methods: This case report details a 70-year-old female patient with a refractory macular hole in the left eye, who underwent pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, gas tamponade, and subretinal injection of BSS. Results: One month postoperatively, optical coherence tomography (OCT) confirmed successful closure of the macular hole, with best-corrected visual acuity (BCVA) improving to 20/100 in the affected eye. At six-month follow-up, the macular hole remained closed, and OCT revealed partial restoration of the ellipsoid zone and external limiting membrane. BCVA was maintained at 20/100. Conclusion: Subretinal BSS injection appears to be an effective technique for closing refractory macular holes, offering a promising option for complex cases.
- 10 December 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Apresentação atípica da ceratite herpética em lactente
- 10 December 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Apresentação atípica da ceratite herpética em lactente
- Open Access
- 16 April 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Congenital stationary night blindness linked to a CACNA1F gene mutation
Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them [...] ABSTRACT Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them
- 16 April 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Open AccessCongenital stationary night blindness linked to a CACNA1F gene mutation
Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them [...] ABSTRACT Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them
- Open Access
- 5 February 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study*
Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised [...] ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised
- 5 February 2025
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 84
Open AccessOcular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study*
Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised [...] ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised